GSA Capital Partners’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-212,518	Closed	-$1.07M	–	1620
2025 Q3	$1.07M	Sell	212,518 -26,021	-11%	-$115K	0.09%	358
2025 Q2	$818K	Sell	238,539 -28,356	-11%	-$70.6K	0.06%	584
2025 Q1	$595K	Sell	266,895 -322,318	-55%	-$924K	0.05%	675
2024 Q4	$1.73M	Buy	589,213 +347,347	+144%	+$967K	0.13%	128
2024 Q3	$629K	Buy	241,866 +219,703	+991%	+$609K	0.05%	762
2024 Q2	$66K	Sell	22,163 -63,957	-74%	-$242K	﹤0.01%	1554
2024 Q1	$390K	Sell	86,120 -264,550	-75%	-$1.35M	0.03%	1061
2023 Q4	$2M	Buy	350,670 +204,480	+140%	+$948K	0.17%	117
2023 Q3	$672K	Buy	146,190 +135,504	+1,268%	+$824K	0.06%	615
2023 Q2	$69K	Buy	+10,686	New	+$72.9K	0.01%	1403
2023 Q1	–	Sell	-111,894	Closed	-$1.13M	–	1431
2022 Q4	$1.13M	Buy	+111,894	New	+$1.29M	0.14%	157
2022 Q3	–	Sell	-68,466	Closed	-$729K	–	1463
2022 Q2	$729K	Buy	68,466 +51,478	+303%	+$436K	0.11%	283
2022 Q1	$166K	Buy	+16,988	New	+$161K	0.02%	1215